AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION
Authors: SOCIE G CAYUELA JM RAYNAL B ESPEROU H FUND X RAFFOUX C DEVERGIE A RIBAUD P MAROLLEAU JP PARQUET N SIGAUX F BRISON O GLUCKMAN E
Citation: G. Socie et al., INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION, Leukemia, 12(9), 1998, pp. 1440-1446
TRANSPLANTATION FOR FANCONIS-ANEMIA (FA) - LONG-TERM FOLLOW-UP OF 50 PATIENTS (PTS) TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING
Authors: SOCIE G DEVERGIE A GIRINSKI T PIEL G RIBAUD P ESPEROU H PARQUET N BRISON O GLUCKMAN E
Citation: G. Socie et al., TRANSPLANTATION FOR FANCONIS-ANEMIA (FA) - LONG-TERM FOLLOW-UP OF 50 PATIENTS (PTS) TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING, Bone marrow transplantation, 21, 1998, pp. 168-168
ADVANTAGES OF GENO IDENTICAL BMT WITH A NON TOXIC CONDITIONING REGIMEN AS FIRST LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA
Authors: DEVERGIE A PARQUET N GARDERET L ESPEROU H SOCIE G RIBAUD P GLUCKMAN E
Citation: A. Devergie et al., ADVANTAGES OF GENO IDENTICAL BMT WITH A NON TOXIC CONDITIONING REGIMEN AS FIRST LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 286-286
PREDICTIVE FACTORS OF DEATH IN BMT PATIENTS ADMITTED TO INTENSIVE-CARE UNIT
Authors: CHEN Y LELEU G RIBAUD P AZOULAY E SOCIE G GLUCKMAN E SCHLEMMER B
Citation: Y. Chen et al., PREDICTIVE FACTORS OF DEATH IN BMT PATIENTS ADMITTED TO INTENSIVE-CARE UNIT, Bone marrow transplantation, 21, 1998, pp. 306-306
USE OF FILTERED BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS (CMV) INFECTION AFTER ALLOGENEIC MARROW TRANSPLANT
Authors: TRAINEAU R SCIEUX C AGBALIKA F RIBAUD P SOCIE G ESPEROU H DEVERGIE A PARQUET N BENBUNAN M GLUCKMAN E
Citation: R. Traineau et al., USE OF FILTERED BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS (CMV) INFECTION AFTER ALLOGENEIC MARROW TRANSPLANT, Bone marrow transplantation, 21, 1998, pp. 475-475
MOLECULAR TYPING OF ENVIRONMENTAL AND PATIENT ISOLATES OF ASPERGILLUS-FUMIGATUS FROM VARIOUS HOSPITAL SETTINGS
Authors: CHAZALET V DEBEAUPUIS JP SARFATI J LORTHOLARY J RIBAUD P SHAH P CORNET M THIEN HV GLUCKMAN E BRUCKER G LATGE JP
Citation: V. Chazalet et al., MOLECULAR TYPING OF ENVIRONMENTAL AND PATIENT ISOLATES OF ASPERGILLUS-FUMIGATUS FROM VARIOUS HOSPITAL SETTINGS, Journal of clinical microbiology, 36(6), 1998, pp. 1494-1500
HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA
Authors: MEIGNIN V DEVERGIE A BRICE P BRISON O PARQUET N RIBAUD P COJEAN I GAULARD P GLUCKMAN E SOCIE G JANIN A
Citation: V. Meignin et al., HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA, Transplantation, 65(4), 1998, pp. 595-597
UNUSUAL COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA
Authors: ROCHA V DEVERGIE A SOCIE G RIBAUD P ESPEROU H PARQUET N GLUCKMAN E
Citation: V. Rocha et al., UNUSUAL COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA, British Journal of Haematology, 103(1), 1998, pp. 243-248
TRANSPLANTATION FOR FANCONI ANEMIA - LONG-TERM FOLLOW-UP OF 50 PATIENTS TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING
Authors: SOCIE G DEVERGIE A GIRINSKI T PIEL G RIBAUD P ESPEROU H PARQUET N MAAREK O NOGUERA MH RICHARD P BRISON O GLUCKMAN E
Citation: G. Socie et al., TRANSPLANTATION FOR FANCONI ANEMIA - LONG-TERM FOLLOW-UP OF 50 PATIENTS TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING, British Journal of Haematology, 103(1), 1998, pp. 249-255
HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA
Authors: MEIGNIN V DEVERGIE A BRICE P BRISON O PARQUET N RIBAUD P COJEAN I GAULARD P GLUCKMAN E SOCIE G JANIN A
Citation: V. Meignin et al., HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 211-211
BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA (T-MDS) AND ACUTE-LEUKEMIA (T-AL) - EXPERIENCE OF SAINT-LOUIS-HOSPITAL (PARIS)
Authors: YAKOUBAGHA I RIBAUD P DEVERGIE A GARNIER F DAMAJ G ROCHA V GARDERET L SELIMI F GUARDIOLA P SOCIE G ESPEROU H GLUCKMAN E
Citation: I. Yakoubagha et al., BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA (T-MDS) AND ACUTE-LEUKEMIA (T-AL) - EXPERIENCE OF SAINT-LOUIS-HOSPITAL (PARIS), British Journal of Haematology, 102(1), 1998, pp. 317-317
INDICATIONS AND TIMING OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES
Authors: SUTTON L LEBLOND V RIBAUD P JOUET JP
Citation: L. Sutton et al., INDICATIONS AND TIMING OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 27(5-6), 1997, pp. 475-485
FUNGAL-INFECTIONS AND THE CANCER-PATIENT
Authors: RIBAUD P
Citation: P. Ribaud, FUNGAL-INFECTIONS AND THE CANCER-PATIENT, European journal of cancer, 33, 1997, pp. 50-54
SHORT-TERM AND LONG-TERM FOLLOW-UP OF THYROID-DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITHOUT THE USE OF PREPARATIVE TOTAL-BODY IRRADIATION
Authors: TOUBERT ME SOCIE G GLUCKMAN E ARACTINGI S ESPEROU H DEVERGIE A RIBAUD P PARQUET N SCHLAGETER MH BERESSI JP RAIN JD VEXIAU P
Citation: Me. Toubert et al., SHORT-TERM AND LONG-TERM FOLLOW-UP OF THYROID-DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITHOUT THE USE OF PREPARATIVE TOTAL-BODY IRRADIATION, British Journal of Haematology, 98(2), 1997, pp. 453-457
PRELIMINARY-RESULTS OF CIDOFOVIR (HPMPC) FOR THE TREATMENT OF ADENOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PATIENTS
Authors: RIBAUD P SCIEUX C PARQUET N CARBONNEL E SOCIE G EMPEROU H DEVERGIE A SELIMI F GLUCKMAN E
Citation: P. Ribaud et al., PRELIMINARY-RESULTS OF CIDOFOVIR (HPMPC) FOR THE TREATMENT OF ADENOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PATIENTS, Blood, 90(10), 1997, pp. 4432-4432
VENOOCCLUSIVE DISEASE AFTER BONE-MARROW T RANSPLANTATION - USE OF HEPARIN FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE
Authors: PARQUET N DEVERGIE A SOCIE G RIBAUD P ESPEROU H GLUCKMAN E
Citation: N. Parquet et al., VENOOCCLUSIVE DISEASE AFTER BONE-MARROW T RANSPLANTATION - USE OF HEPARIN FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE, Annales de medecine interne, 148(2), 1997, pp. 132-135
RAPD TYPING OF ASPERGILLUS-FUMIGATUS STRA INS - EPIDEMIOLOGIC APPLICATIONS ON A HOSPITAL SITE
Authors: SORIAROYER C BOUGNOUX ME SULAHIAN A RIBAUD P TRAORE F GARIN YJF GLUCKMAN E DEROUIN F
Citation: C. Soriaroyer et al., RAPD TYPING OF ASPERGILLUS-FUMIGATUS STRA INS - EPIDEMIOLOGIC APPLICATIONS ON A HOSPITAL SITE, Journal de mycologie medicale, 6(2), 1996, pp. 49-55
CRITICAL-REVIEW OF LIPID AMPHOTERICIN-B FORMULATIONS AS TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGICAL DISORDERS OR BONE-MARROW TRANSPLANTATION (BMT)
Authors: RIBAUD P GLUCKMAN E
Citation: P. Ribaud et E. Gluckman, CRITICAL-REVIEW OF LIPID AMPHOTERICIN-B FORMULATIONS AS TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGICAL DISORDERS OR BONE-MARROW TRANSPLANTATION (BMT), Journal de mycologie medicale, 6, 1996, pp. 17-20
COMPARISON OF AN ENZYME-IMMUNOASSAY AND LATEX AGGLUTINATION-TEST FOR DETECTION OF GALACTOMANNAN IN THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS
Authors: SULAHIAN A TABOURET M RIBAUD P SARFATI J GLUCKMAN E LATGE JP DEROUIN F
Citation: A. Sulahian et al., COMPARISON OF AN ENZYME-IMMUNOASSAY AND LATEX AGGLUTINATION-TEST FOR DETECTION OF GALACTOMANNAN IN THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS, European journal of clinical microbiology & infectious diseases, 15(2), 1996, pp. 139-145
DIFFERENT ETIOLOGIES OF REVERSIBLE MRI ABNORMALITIES IN TRANSPLANT RECIPIENTS
Authors: MIAUX Y RIBAUD P
Citation: Y. Miaux et P. Ribaud, DIFFERENT ETIOLOGIES OF REVERSIBLE MRI ABNORMALITIES IN TRANSPLANT RECIPIENTS, Neuroradiology, 38(7), 1996, pp. 688-688
MR AND CHEMOTHERAPY
Authors: MIAUX Y RIBAUD P WEILL A MARTINDUVERNEUIL N COGNARD C SAVIN D CHIRAS J
Citation: Y. Miaux et al., MR AND CHEMOTHERAPY, Neurology, 47(5), 1996, pp. 1355-1355
FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS
Authors: SUTTON L CHASTANG C RIBAUD P JOUET JP KUENTZ M ATTAL M REIFFERS J TIGAUD JM RIO B DAURIAC C LEGROS M DREYFUS F LIOURE B TROUSSARD X MILPIED N WITZ F ORIOL P CAHN JY MICHALLET M GLUCKMAN E IFRAH N PICO JL VILMER E LEBLOND V
Citation: L. Sutton et al., FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS, Blood, 88(1), 1996, pp. 358-365
AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS
Authors: PARQUET N RIBAUD P CHASTANG C LATGE JP SARFATI J BAFFROYLAFITTE L DEVERGIE A ESPEROUBOURDEAU H TRAORE F BOUAKLINE A DEKERVILER E GLUCKMAN E
Citation: N. Parquet et al., AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS, Experimental hematology, 23(8), 1995, pp. 856-856
HEPATITIS-C INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTED PATIENTSAFTER INFUSIONS OF INTRAVENOUS IMMUNOGLOBULIN
Authors: TRAINEAU R LOISEAU P GANGNEUX JP RAVERA N BENBUNAN M SOCIE G RIBAUD P GLUCKMAN E
Citation: R. Traineau et al., HEPATITIS-C INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTED PATIENTSAFTER INFUSIONS OF INTRAVENOUS IMMUNOGLOBULIN, Experimental hematology, 23(8), 1995, pp. 859-859
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 2ND REMISSION - FACTORS PREDICTIVE OF SURVIVAL, RELAPSE AND GRAFT-VERSUS-HOST DISEASE
Authors: MOUSSALEM M BOURDEAU HE DEVERGIE A BARUCHEL A RIBAUD P SOCIE G PARQUET N TRAINEAU R HIRSCH I SCHAISON G GLUCKMAN E
Citation: M. Moussalem et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 2ND REMISSION - FACTORS PREDICTIVE OF SURVIVAL, RELAPSE AND GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 15(6), 1995, pp. 943-947
Risultati: 1-25 | 26-38